Related content

Reduction of Factor FVIIa Activity During Heparin Therapy - Evidence for Assay Interactions with Tissue Factor Pathway Inhibitor and Antithrombin

By Hansen J.-B.   Svensson B.   Sandset P.M.   Thijssen F.  

Thrombosis Research, Vol. 100, Iss. 5, 2000-12 ,pp. : 389-396

Elsevier

Access to resources Recommend Favorite

Insertion of the Asp-Ser/Phe Sequence in the P' Position of Hirutonin Provides Molecules Having Both Antithrombin and Disintegrin Activity - Evaluation of conformationally constrained RGD peptides

By Leblond L.   DiMaio J.   Winocour P.D.  

Thrombosis Research, Vol. 93, Iss. 4, 1999-02 ,pp. : 171-181

Elsevier

Access to resources Recommend Favorite

In vitro effect of melagatran and lepirudin on clot-bound thrombin

By Lebrazi J.   Elalamy I.   Samama M.M.  

Thrombosis Research, Vol. 110, Iss. 4, 2003-06 ,pp. : 249-252

Elsevier

Access to resources Recommend Favorite

Chemical Sulfonation and Anticoagulant Activity of Acharan Sulfate - Antithrombin III-and heparin cofactor II-independent inhibition of factor X activation by factor IXa-Factor VIIIa complex and heparin cofactor II-dependent inhibition of thrombin

By Wu S.J.   Chun M.W.   Shin K.H.   Toida T.   Park Y.   Linhardt R.J.   Kim Y.S.  

Thrombosis Research, Vol. 92, Iss. 6, 1998-12 ,pp. : 273-281

Elsevier

Access to resources Recommend Favorite

Treatment of Patients with a History of Heparin-Induced Thrombocytopenia and Anti-Lepirudin Antibodies with Argatroban

By Job Harenberg   Ingrid Jörg   Tivadar Fenyvesi   Lukas Piazolo  

Journal of Thrombosis and Thrombolysis, Vol. 19, Iss. 1, 2005-02 ,pp. : 65-69

Springer Publishing Company

Access to resources Recommend Favorite